Vertex PharmaNASDAQ:VRTX is on a verge of a breakout. AMEX:XPH is also staging a recovery, but still trading below key levels. For now, the focus in on a NASDAQ:VRTX look position. Longby Trend_Trader_JSE0
XPH | Pharmaceuticals to Outperform- Price is breaking minor falling wedge pattern on strong volume - Pharmaceutical stocks have lagged the broader market in the past year and have not been so inexpensive relative to the S&P 500 in at least 20 years - As the healthcare sector is starting to out perform the overall market, I have been locking in gains on some cyclical stocks and positioning more defensive - I expect pharmaceuticals to outperform the market and sector in the short term as investor seek value in a richly priced stock market by 0dteTraders0
ETFs potential BUYS -XPH-EIDO-EUO-XBI-BIBFor Monday’s open, 5 ETF's are potential buys under my rules for Pullback Strategy. This strategy identifies oversold ETFs and takes advantage of the tendency for prices to revert to the mean in the short term. The ETFs set up as potential buys for Monday are listed in the table below: XPH -SPDR S&P Pharmaceuticals EIDO - Indonesia Invstble Mkt Idx MSCI EUO - Ultrashort Euro Proshares XBI - SPDR S&P Biotech BIB - Ultra Nasdaq Biotechnology ProshLongby DaChi0